Warfarin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

Anticoagulation in Post MI LV Thrombus Trial in Nepal
Conditions:   Left Ventricular Thrombus;   Myocardial Infarction Interventions:   Drug: Rivaroxaban;   Drug: Warfarin Sponsor:   Shahid Gangalal National Heart Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials

Treatment Patterns Among Patients With Venous Thromboembolism in the United States
Condition:   Venous Thromboembolism Interventions:   Drug: apixaban;   Drug: warfarin Sponsors:   Pfizer;   Bristol-Myers Squibb Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials

Anticoagulation in Post MI LV Thrombus Trial in Nepal
Conditions:   Left Ventricular Thrombus;   Myocardial Infarction Interventions:   Drug: Rivaroxaban;   Drug: Warfarin Sponsor:   Shahid Gangalal National Heart Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials

Treatment Patterns Among Patients With Venous Thromboembolism in the United States
Condition:   Venous Thromboembolism Interventions:   Drug: apixaban;   Drug: warfarin Sponsors:   Pfizer;   Bristol-Myers Squibb Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials

Anticoagulation in Post MI LV Thrombus Trial in Nepal
Conditions:   Left Ventricular Thrombus;   Myocardial Infarction Interventions:   Drug: Rivaroxaban;   Drug: Warfarin Sponsor:   Shahid Gangalal National Heart Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials

Treatment Patterns Among Patients With Venous Thromboembolism in the United States
Condition:   Venous Thromboembolism Interventions:   Drug: apixaban;   Drug: warfarin Sponsors:   Pfizer;   Bristol-Myers Squibb Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials

Anticoagulation in Post MI LV Thrombus Trial in Nepal
Conditions:   Left Ventricular Thrombus;   Myocardial Infarction Interventions:   Drug: Rivaroxaban;   Drug: Warfarin Sponsor:   Shahid Gangalal National Heart Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials

Treatment Patterns Among Patients With Venous Thromboembolism in the United States
Condition:   Venous Thromboembolism Interventions:   Drug: apixaban;   Drug: warfarin Sponsors:   Pfizer;   Bristol-Myers Squibb Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials

Anticoagulation in Post MI LV Thrombus Trial in Nepal
Conditions:   Left Ventricular Thrombus;   Myocardial Infarction Interventions:   Drug: Rivaroxaban;   Drug: Warfarin Sponsor:   Shahid Gangalal National Heart Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials

Treatment Patterns Among Patients With Venous Thromboembolism in the United States
Condition:   Venous Thromboembolism Interventions:   Drug: apixaban;   Drug: warfarin Sponsors:   Pfizer;   Bristol-Myers Squibb Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials

Anticoagulation in Post MI LV Thrombus Trial in Nepal
Conditions:   Left Ventricular Thrombus;   Myocardial Infarction Interventions:   Drug: Rivaroxaban;   Drug: Warfarin Sponsor:   Shahid Gangalal National Heart Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials

Treatment Patterns Among Patients With Venous Thromboembolism in the United States
Condition:   Venous Thromboembolism Interventions:   Drug: apixaban;   Drug: warfarin Sponsors:   Pfizer;   Bristol-Myers Squibb Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials

Anticoagulation in Post MI LV Thrombus Trial in Nepal
Conditions:   Left Ventricular Thrombus;   Myocardial Infarction Interventions:   Drug: Rivaroxaban;   Drug: Warfarin Sponsor:   Shahid Gangalal National Heart Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials

Treatment Patterns Among Patients With Venous Thromboembolism in the United States
Condition:   Venous Thromboembolism Interventions:   Drug: apixaban;   Drug: warfarin Sponsors:   Pfizer;   Bristol-Myers Squibb Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials

Anticoagulation in Post MI LV Thrombus Trial in Nepal
Conditions:   Left Ventricular Thrombus;   Myocardial Infarction Interventions:   Drug: Rivaroxaban;   Drug: Warfarin Sponsor:   Shahid Gangalal National Heart Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials